![Lynette Herscha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lynette Herscha
Operationeel Directeur bij
Immunitas Therapeutics, Inc.
Profiel
Lynette Herscha is currently the Chief Operating Officer at Immunitas Therapeutics, Inc. She previously worked as the Secretary & General Counsel at Concert Pharmaceuticals, Inc. from 2017 to 2019.
She also held the position of Secretary & Chief Legal Officer at Solid Biosciences, Inc. Ms. Herscha received her undergraduate degree from Boston University and her graduate degree from Boston University School of Law.
Actieve functies van Lynette Herscha
| Bedrijven | Functie | Begin |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Operationeel Directeur | 13-07-2022 |
Eerdere bekende functies van Lynette Herscha
| Bedrijven | Functie | Einde |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-01-2019 |
| SOLID BIOSCIENCES INC. | Algemeen Adviseur | - |
Opleiding van Lynette Herscha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
